Hakimeh Ebrahimi-Nik

In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer

Juan Dubrot, Peter P. Du, Sarah Kate Lane-Reticker et al. · Nature Immunology · 2022 · 222 citations

Medicine, Cancer Biology, Immunology +14

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

Christina K. Baumgartner, Hakimeh Ebrahimi-Nik, Arvin Iracheta‐Vellve et al. · Nature · 2023 · 174 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Mass spectrometry–driven exploration reveals nuances of neoepitope-driven tumor rejection

Hakimeh Ebrahimi-Nik, Justine Michaux, William L. Corwin et al. · JCI Insight · 2019 · 77 citations · Full text

Life Sciences, Immunology, Oncology +17

Bacterial ghost of avian pathogenic E. coli (APEC) serotype O78:K80 as a homologous vaccine against avian colibacillosis

Hakimeh Ebrahimi-Nik, Mohammad Reza Bassami, Mehrdad Mohri et al. · PLoS ONE · 2018 · 50 citations · Full text

Life Sciences, Biotechnology, Microbiology +17

Tumor Control Index as a new tool to assess tumor growth in experimental animals

William L. Corwin, Hakimeh Ebrahimi-Nik, Stephanie M. Floyd et al. · Journal of Immunological Methods · 2017 · 34 citations · Full text

Medicine, Immunology, Oncology +10